EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synergistic Enhancement of 5-Fluorouracil Chemotherapeutic Efficacy by Taurine in Colon Cancer Rat Model

Daniela Hartmann Jornada, Diogo Boreski iD, Diego Eidy Chiba iD, Denise Ligeiro, Marcus Alexandre Mendes Luz, Edmo Atique Gabriel, Cauê Benito Scarim iD, Cleverton Roberto de Andrade iD, Chung Man Chin iD

Nutrients · 2024

DOI: 10.3390/nu16183047 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2024. Verfasst von Daniela Hartmann Jornada und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Drug Design (LAPDESF), Drugs and Medicines Department, School of Pharmaceutical Sciences, University of São Paulo State, UNESP, Araraq…. Hauptthemen laut MEDLINE: Taurine, Fluorouracil, Colonic Neoplasms, Drug Synergism. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) is one of the top 10 most common cancers worldwide and caused approximately 10 million deaths in 2022. CRC mortality has increased by 10% since 2020 and 52.000 deaths will occur in 2024, highlighting the limitations of current treatments due to ineffectiveness, toxicity, or non-adherence. The widely used chemotherapeutic agent, 5-fluorouracil (5-FU), is associated with several adverse effects, including renal, cardiac, and hepatic toxicity; mucositis; and resistance. Taurine (TAU), an essential β-amino acid with potent antioxidant, antimutagenic, and anti-inflammatory properties, has demonstrated protective effects against tissue toxicity from chemotherapeutic agents like doxorubicin and cisplatin. Taurine deficiency is linked to aging and cancers such as breast and colon cancer. This study hypothesized that TAU may mitigate the adverse effects of 5-fluorouracil (5-FU). Carcinogenesis was chemically induced in rats using 1,2-dimethylhydrazine (DMH). Following five months of cancer progression, taurine (100 mg/kg) was administered orally for 8 days, and colon tissues were analyzed. The results showed 80% of adenocarcinoma (AC) in DMH-induced control animals. Notably, the efficacy of 5-FU showed 70% AC and TAU 50% while, in the 5-FU + TAU group, no adenocarcinoma was observed. No differences were observed in the inflammatory infiltrate or the expression of genes such as K-ras, p53, and Ki-67 among the cancer-induced groups whereas APC/β-catenin expression was increased in the 5FU + TAU-treated group. The mitotic index and dysplasia were increased in the induced 5-FU group and when associated with TAU, the levels returned to normal. These data suggest that 5-FU exhibits a synergic anticancer effect when combined with taurine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TaurineFluorouracilColonic NeoplasmsDrug SynergismAnimalsRatsMaleDisease Models, AnimalAdenocarcinoma1,2-DimethylhydrazineRats, WistarAntineoplastic Combined Chemotherapy Protocols

Stichwörter der Autor:innen

5-fluorouracilchemotherapycolon cancertaurine

Substanzen

TaurineFluorouracil1,2-Dimethylhydrazine

Autor:innen und Institutionen

  • Laboratory for Drug Design (LAPDESF), Drugs and Medicines Department, School of Pharmaceutical Sciences, University of São Paulo State, UNESP, Araraquara 14800-903, SP, Brazil.
  • Physiology and Pathology Department, School of Dentistry, University of São Paulo State, UNESP, Araraquara 14801-385, SP, Brazil.
  • Advanced Research Center in Medicine (CEPAM), School of Medicine, Union of the Colleges of the Great Lakes (UNILAGO), São José do Rio Preto 15030-070, SP, Brazil.

ORCID-Profile: Diogo Boreski, Diego Eidy Chiba, Cauê Benito Scarim, Cleverton Roberto de Andrade, Chung Man Chin

Förderung

  • Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Zitieren

APA

Jornada, D. H., Boreski, D., Chiba, D. E., Ligeiro, D., Luz, M. A. M., Gabriel, E. A., Scarim, C. B., de Andrade, C. R., & Chin, C. M. (2024). Synergistic Enhancement of 5-Fluorouracil Chemotherapeutic Efficacy by Taurine in Colon Cancer Rat Model. Nutrients. https://doi.org/10.3390/nu16183047

Vancouver

Jornada DH, Boreski D, Chiba DE, Ligeiro D, Luz MAM, Gabriel EA, et al. Synergistic Enhancement of 5-Fluorouracil Chemotherapeutic Efficacy by Taurine in Colon Cancer Rat Model. Nutrients. 2024. doi:10.3390/nu16183047

BibTeX
@article{Jornada2024,
  author = {Jornada, Daniela Hartmann and Boreski, Diogo and Chiba, Diego Eidy and Ligeiro, Denise and Luz, Marcus Alexandre Mendes and Gabriel, Edmo Atique and Scarim, Cauê Benito and de Andrade, Cleverton Roberto and Chin, Chung Man},
  title = {Synergistic Enhancement of 5-Fluorouracil Chemotherapeutic Efficacy by Taurine in Colon Cancer Rat Model},
  journal = {Nutrients},
  year = {2024},
  doi = {10.3390/nu16183047}
}
Kostenlos starten →